AreWeCuredYet

AI × Bio. Tracking drug discovery, medical breakthroughs, and the evidence behind the hype.

[AreWeCuredYet @AreWeCuredYet]

Could rentosertib become the first drug with an AI-discovered target AND an AI-designed molecule to meaningfully improve patients’ lives?

It’s in Phase III for idiopathic pulmonary fibrosis.

https://t.co/tUaW4FvF06

[AreWeCuredYet @AreWeCuredYet]

For patients, two AI drug development metrics really matter:

Diseases cured. New drugs approved.

Our curated, FDA-focused tracker still shows 0 / 0. Pretty sobering.

When will that change? ⏳
@sama @fidjissimo @DarioAmodei @elonmusk @nc_frey

[AreWeCuredYet @AreWeCuredYet]

Clinical trials are the biggest bottleneck in modern drug development.

⏳ 6–7 years
💰 $117M per candidate
❌ 86% fail

AI still needs to prove it can reduce time to market, cut costs, and improve clinical trial success rates.

[AreWeCuredYet @AreWeCuredYet]

Can a virtual tumor help pick a real cancer treatment?

UCL tested AI-powered “digital twins” using data from 31 breast cancer patients. The models matched treatment outcomes in 74% of cases.

Early days, but worth watching.

https://t.co/QpfmEixckC